Volume dodolan mangsa ngarep perusahaan: EyePoint Pharmaceuticals (EYPT)

EyePoint Pharmaceuticals generates revenue through the sale of proprietary sustained-release ophthalmic drug delivery systems. Future sales volumes support the current trend, with the indicator remaining around 0.00. Market protection is ensured by stringent patents and a complex FDA approval process. Stable management with a scientific background is currently focusing on completing the final stages of large-scale clinical trials.

EYPT - Volume dodolan sing dikarepake perusahaan EyePoint Pharmaceuticals ing rentang 04.07.2022 - 13.11.2026

Ringkesan rincian data analitis EyePoint Pharmaceuticals Inc (EYPT)

- kuotasi lan prakiraan analis:

Rega saham EyePoint Pharmaceuticals|EYPT - Rata-rata rega prakiraan

- indikator kapitalisasi bursa perusahaan:

Biji pasar EyePoint Pharmaceuticals Inc|EYPT - Total Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Buku saben Saham EyePoint Pharmaceuticals|EYPT - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku eyepointpharma.com|EYPT - Nilai Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas EyePoint Pharmaceuticals|EYPT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal EyePoint Pharma|EYPT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku EyePoint Pharmaceuticals Inc|EYPT - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan EyePoint Pharmaceuticals|Indikator likuiditas cepet eyepointpharma.com

- statistik bathi lan rasio pasar:

EYPT - Bathi pungkasan|Bathi sing dikarepake EyePoint Pharmaceuticals|EYPT - Kapitalisasi marang bathi resik|Pangali Forward P/E EyePoint Pharmaceuticals, Inc.|EYPT - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA EyePoint Pharmaceuticals Inc|EYPT - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan EyePoint Pharmaceuticals|EYPT - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan eyepointpharma.com|EYPT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep EyePoint Pharmaceuticals

- data dodolan lan asil:

EYPT - Pendapatan lan volume dodolan|Prakiraan volume dodolan EyePoint Pharmaceuticals|EYPT - Kapitalisasi marang pendapatan|Multiplikator Forward P/S EyePoint Pharmaceuticals Inc

Analisis dhasar perusahaan:EYPT EyePoint Pharmaceuticals

Produk mawa merek EyePoint Pharmaceuticals Inc

The scientific expertise of EyePoint Pharmaceuticals (EYPT) management in developing sustained-release drug delivery systems for the retina directly drives market expectations for future revenues. By analyzing the company's projected sales volumes, investors can observe the daily revaluation of assets between quarterly reports, enabling them to promptly capture price reactions to news and avoid overpaying for securities during sharp speculative spikes.

Karo sapa EyePoint Pharmaceuticals saingan

Prakiraan volume dodolan ALC|BLCO - Volume dodolan sing dikarepake perusahaan|Glaukos - Volume dodolan mangsa ngarep perusahaan|Apellis Pharmaceuticals, Inc. (APLS) - Volume dodolan sing dikarepake perusahaan|Belite Bio Pharma - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Ocular Pharma|Harrow, Inc. (HROW) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan VRDN (viridiantherapeutics.com)|Prakiraan pendapatan perusahaan LENZ Therapeutics|Volume dodolan sing dikarepake perusahaan Oculis Holding OCS|Prakiraan volume dodolan KOD|Dodolan mangsa ngarep perusahaan aldeyra.com|Prakiraan pendapatan perusahaan KALA BIO KALA|IRD: Prakiraan pendapatan perusahaan|OKYO: Volume dodolan mangsa ngarep perusahaan|Adverum Biotechnologies - Prakiraan volume pendapatan perusahaan|OTLK (Outlook Pharma) - Volume dodolan mangsa ngarep perusahaan|Clearside Corp - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan NovaBay Pharmaceuticals Inc.|Kiora Pharma - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan ALIM|EYEN (eyenovia.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan GHSI (Guardion Health Sciences Inc.)|Prakiraan volume dodolan Ocuphire Corporation OCUP|OPT - Prakiraan pendapatan perusahaan